Avaneesh Kumar Pandey

442 total citations
26 papers, 253 citations indexed

About

Avaneesh Kumar Pandey is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Surgery. According to data from OpenAlex, Avaneesh Kumar Pandey has authored 26 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Applied Microbiology and Biotechnology, 5 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in Avaneesh Kumar Pandey's work include Antibiotic Use and Resistance (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Pharmaceutical Economics and Policy (4 papers). Avaneesh Kumar Pandey is often cited by papers focused on Antibiotic Use and Resistance (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Pharmaceutical Economics and Policy (4 papers). Avaneesh Kumar Pandey collaborates with scholars based in India, United Kingdom and South Africa. Avaneesh Kumar Pandey's co-authors include Samir Malhotra, Nusrat Shafiq, Nusrat Shafiq, Navjot Kaur, Srinivas Gosla Reddy, Samir Malhotra, Esmita Charani, Marc Mendelson, Manica Balasegaram and Alison Holmes and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Microbiology and Infection.

In The Last Decade

Avaneesh Kumar Pandey

23 papers receiving 246 citations

Peers

Countries citing papers authored by Avaneesh Kumar Pandey

Since Specialization

Citations

This map shows the geographic impact of Avaneesh Kumar Pandey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avaneesh Kumar Pandey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avaneesh Kumar Pandey more than expected).

Fields of papers citing papers by Avaneesh Kumar Pandey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avaneesh Kumar Pandey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avaneesh Kumar Pandey. The network helps show where Avaneesh Kumar Pandey may publish in the future.

Co-authorship network of co-authors of Avaneesh Kumar Pandey

This figure shows the co-authorship network connecting the top 25 collaborators of Avaneesh Kumar Pandey. A scholar is included among the top collaborators of Avaneesh Kumar Pandey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avaneesh Kumar Pandey. Avaneesh Kumar Pandey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages 2024 ·Clinical Microbiology and Infection ·Avaneesh Kumar Pandey, Jennifer Cohn, Vrinda Nampoothiri, U. Gadde, (unknown), Ashish Kumar Kakkar, Yogendra Kumar Gupta, Samir Malhotra, Oluchi Mbamalu, Marc Mendelson, Anne‐Grete Märtson, (unknown), Thomas Tängdén, Nusrat Shafiq, Esmita Charani	14
2	Dostarlimab: Review on success story and clinical trials 2024 ·Critical Reviews in Oncology/Hematology ·Rohitash Yadav, (unknown), (unknown), Avaneesh Kumar Pandey, (unknown), Neeraj Jain	3
3	Clinical pharmacokinetics of antimicrobials in critical care: a narrative review 2024 ·Expert Review of Anti-infective Therapy ·(unknown), (unknown), Nusrat Shafiq, Avaneesh Kumar Pandey, Samir Malhotra	1
4	Addressing Challenges in Antibiotic Access: Barriers, Implications and Strategies for Solution 2024 ·Pharmaceutical Medicine ·(unknown), Avaneesh Kumar Pandey, Samir Malhotra, Ashish Kumar Kakkar, (unknown), Jennifer Cohn, Alison Holmes, Esmita Charani, Nusrat Shafiq	3
5	Antimicrobial drug pricing 2024 ·SHILAP Revista de lepidopterología ·Avaneesh Kumar Pandey, Nusrat Shafiq, Ashish Kumar Kakkar, Samir Malhotra, Beth Woods, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
6	Comparison of 4D computed tomography and F‐18 fluorocholine PET for localisation of parathyroid lesions in primary hyperparathyroidism: A systematic review and meta‐analysis 2023 ·Clinical Endocrinology ·(unknown), (unknown), Avaneesh Kumar Pandey, (unknown), (unknown), (unknown), (unknown), Sanjay Kumar Bhadada, (unknown)	8
7	Bio‐evaluation of poly(lactic‐co‐glycolic) acid nanoparticles loaded with radiolabelled rifampicin 2023 ·British Journal of Clinical Pharmacology ·(unknown), Nusrat Shafiq, Jaya Shukla, (unknown), (unknown), (unknown), Avaneesh Kumar Pandey, Bhagwant Rai Mittal, G. K. Khuller, Navneet Sharma, Samir Malhotra	5
8	Population Pharmacokinetics of Hydroxychloroquine Sulfate in Healthcare Workers, Given for Prophylaxis Against Coronavirus Disease 2019 (COVID‐19) in India 2022 ·The Journal of Clinical Pharmacology ·Jeffrey Pradeep Raj, Nithya Gogtay, Avaneesh Kumar Pandey, Ashish Kumar Kakkar, Nusrat Shafiq, (unknown), Usharani Pingali, (unknown), Surulivelrajan Mallayasamy, Nilima Kshirsagar	1
9	Antibiotic Prophylaxis for Orthopaedic Implant Removal: What Does theEvidence Say? 2022 ·Current Drug Safety ·Nusrat Shafiq, (unknown), Avaneesh Kumar Pandey, (unknown), Samir Malhotra, (unknown)	0
10	Colistin disposition in the cerebrospinal fluid when administered either intravenously alone or with intraventricular/intrathecally in neonates/pediatric patients with culture-proven meningitis 2022 ·Pediatrics & Neonatology ·(unknown), Avaneesh Kumar Pandey, Nusrat Shafiq, Jogender Kumar, Samir Malhotra, (unknown), (unknown), Vikas Gautam, Pallab Ray, Naveen Sankhyan, (unknown), Praveen Kumar, (unknown), Savita Verma Attri	4
11	A study to explore the appropriateness of dosing regimen of vancomycin in critically ill patients in a tertiary care unit of India 2022 ·GERMS ·(unknown), (unknown), Nusrat Shafiq, Vikram Gota, Anand Patil, Avaneesh Kumar Pandey, (unknown), (unknown), (unknown), Navneet Sharma, (unknown), (unknown), Sunil Sharma, Samir Malhotra	2
12	Genetic and Nongenetic Determinants of Variable Warfarin Dose Requirements: A Report from North India 2021 ·Public Health Genomics ·Navjot Kaur, Avaneesh Kumar Pandey, Nusrat Shafiq, Ankur Gupta, Reena Das, Harkant Singh, Jasmina Ahluwalia, Samir Malhotra	5
13	Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets 2021 ·Cells ·Jitendra Kumar Chaudhary, Rohitash Yadav, Pankaj Kumar Chaudhary, (unknown), (unknown), Faizul Azam, Jyoti Mehta, Shailendra Handu, Ramasare Prasad, Neeraj Jain, Avaneesh Kumar Pandey, Puneet Dhamija	4
14	Assessment of Appropriateness of Antimicrobial Therapy in Resource-Constrained Settings: Development and Piloting of a Novel Tool—AmRAT 2021 ·Antibiotics ·Ashish Kumar Kakkar, Nusrat Shafiq, (unknown), Ritin Mohindra, Navjot Kaur, Nanda Gamad, (unknown), Dimple Kondal, Samir Malhotra, Praveen Kumar, (unknown), (unknown), Ankit Kumar, (unknown), Avaneesh Kumar Pandey, (unknown), (unknown), (unknown), (unknown), (unknown)	4
15	Shortage of essential antimicrobials: a major challenge to global health security 2021 ·BMJ Global Health ·Nusrat Shafiq, Avaneesh Kumar Pandey, Samir Malhotra, Alison Holmes, Marc Mendelson, Rohit Malpani, Manica Balasegaram, Esmita Charani	68
16	In vitro and in vivo evaluation of clastogenicity of second-line antitubercular drug loaded PLGA nanoparticles 2020 ·Human & Experimental Toxicology ·Avaneesh Kumar Pandey, Rajendra Kumar, Nusrat Shafiq, (unknown), (unknown), (unknown), Sunil Arora, Neelam Varma, Samir Malhotra	3
17	Effect of Acyclovir Solid Lipid Nanoparticles for the Treatment of Herpes Simplex Virus (HSV) Infection in an Animal Model of HSV-1 Infection 2019 ·Pharmaceutical Nanotechnology ·(unknown), Nusrat Shafiq, Indu Pal Kaur, Mini P. Singh, Avaneesh Kumar Pandey, Radha Kanta Ratho, Samir Malhotra	28
18	A meta-analysis to assess usefulness of procalcitonin-guided antibiotic usage for decision making 2017 ·The Indian Journal of Medical Research ·Nusrat Shafiq, Vikas Gautam, Avaneesh Kumar Pandey, Navjot Kaur, (unknown), (unknown), Sharonjeet Kaur, Pallab Ray, Samir Malhotra	6
19	Effect of HDL-Raising Drugs on Cardiovascular Outcomes: A Systematic Review and Meta-Regression 2014 ·PLoS ONE ·Navjot Kaur, Avaneesh Kumar Pandey, (unknown), Nusrat Shafiq, Srinivas Gosla Reddy, (unknown), (unknown), Samir Malhotra	63
20	Terminalia arjunain Chronic Stable Angina: Systematic Review and Meta-Analysis 2014 ·Cardiology Research and Practice ·Navjot Kaur, Nusrat Shafiq, (unknown), Avaneesh Kumar Pandey, Srinivas Gosla Reddy, (unknown), (unknown), Samir Malhotra	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact